Prometheus Biosciences, Inc.

RXDXDelisted Jun 16, 2023

Industry: Pharmaceutical Preparations
SEC CIK: 0001718852

SEC filings (opens in a new tab)

Prometheus Biosciences, Inc. was delisted on Jun 16, 2023; its insiders filed their last Form 4 on Jun 16, 2023; 220 institutions reported holding it in 13F filings for Q1 2023, worth $4.35B in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Prometheus Biosciences, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of RXDX: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	74	103	+29
Shares	25.6M	27.7M	+2.09M (+8.2%)
Value	$1.01B	$1.04B	+$37.5M (+3.7%)

New holders (34)

Institutions that held Prometheus Biosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to RXDX in Q1 2022
Institution	Shares	Value	% of portfolio
Boxer Capital, LLC	1,714,000	$64.7M	3.33%
Decheng Capital Management III (Cayman), LLC	250,000	$9.44M	2.89%
Marshall Wace, LLP	246,855	$9.32M	0.02%
Deep Track Capital, LP	245,000	$9.25M	0.60%
Nicholas Investment Partners, LP	187,080	$7.06M	0.50%
Tri Locum Partners LP	149,066	$5.63M	2.20%
Voloridge Investment Management, LLC	107,696	$4.07M	0.02%
Russell Investments Group, Ltd.	59,216	$2.23M	0.00%
Calamos Advisors LLC	47,690	$1.80M	0.01%
Rafferty Asset Management, LLC	43,860	$1.66M	0.01%
Alliancebernstein L.P.	30,200	$1.14M	0.00%
First Trust Advisors LP	30,017	$1.13M	0.00%
Cinctive Capital Management LP	29,640	$1.12M	0.05%
Tekla Capital Management LLC	22,115	$835.0K	0.03%
Dimensional Fund Advisors LP	18,904	$714.0K	0.00%
Citadel Advisors LLC	13,697	$518.0K	0.00%
Arrowstreet Capital, Limited Partnership	11,684	$441.0K	0.00%
Susquehanna International Group, LLP	11,488	$434.0K	0.00%
Erste Asset Management GmbH	8,800	$330.4K	0.01%
UBS Asset Management Americas Inc	6,200	$234.1K	0.00%
Values First Advisors, Inc.	6,008	$227.0K	0.14%
Occudo Quantitative Strategies LP	5,360	$202.0K	0.02%
Virtu Financial LLC	5,311	$201.0K	0.01%
Barclays PLC	4,992	$189.0K	0.00%
Prospera Financial Services Inc	4,125	$156.0K	0.01%
Amalgamated Bank	3,782	$143.0K	0.00%
Amalgamated Financial Corp.	3,782	$143.0K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	2,289	$86.0K	0.00%
Ensign Peak Advisors, Inc	1,560	$59.0K	0.00%
Nisa Investment Advisors, LLC	830	$31.0K	0.00%
Quantbot Technologies LP	420	$15.0K	0.00%
Dark Forest Capital Management LP	353	$13.0K	0.00%
TCI Wealth Advisors, Inc.	133	$5.00K	0.00%
Covestor Ltd	9	$0	0.00%

Sold out (5)

Institutions that held Prometheus Biosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of RXDX in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
OrbiMed Advisors LLC	250,000	$9.88M
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)	200,000	$7.91M
Long Focus Capital Management, LLC	16,824	$665.0K
SG Americas Securities, LLC	7,659	$303.0K
Jump Financial, LLC	5,802	$229.0K